Elsevier Announces the Launch of a New Journal: Current Opinion in Behavioral Sciences
OXFORD, England, June 30, 2014 /PRNewswire/ –
Elsevier [http://www.elsevier.com/_nocache ], a world-leading provider of scientific,
technical and medical information products and services, today announced the launch of a
new review journal: Current Opinion in Behavioral Sciences.
The journal serves as an educational forum for review papers providing updates on the
expanding volume of information published in the field of behavioral sciences. Papers will
reflect the wide range of multidisciplinary approaches that are used to investigate
questions in this field, including, among others, computational modeling,
genetics/epigenetics, and neuroscience.
The journal will be co-edited by Professors Trevor Robbins (University of Cambridge)
and Cindy Lustig (University of Michigan).
“In Current Opinion in Behavioral Sciences we aim to showcase novel breakthroughs and
significant trends in all aspects of behavioral science, as well as highlight how
behavioral science may enhance or support research in other disciplines, such as biology,
economics, sociology, ecology and computational modeling,” explained Professor Robbins.
“There is an ever-expanding range of methods for investigating questions about
behavior, and it’s becoming increasingly critical – both for current research and training
the next generation of scientists – to understand and integrate the information obtained
from this diversity,” said Professor Lustig. “We plan to make the journal a place where
the most exciting and up-to-date ideas within each area are presented and can be further
“We are very excited about the launch of Current Opinion in Behavioral Sciences as we
believe there is a profound need for a systematic review journal in this rapidly
developing field. We plan to make it a place where exciting and up-to-date ideas are
shared and advanced,” said Toby Charkin, Executive Publisher at Elsevier.
Review articles in Current Opinion in Behavioral Sciences are by invitation only.
First review papers will appear online on ScienceDirect [http://www.sciencedirect.com ] in
September 2014; the first issue will be published in February 2015.
For more information, go to:
Elsevier is a world-leading provider of information solutions that enhance the
performance of science, health, and technology professionals, empowering them to make
better decisions, deliver better care, and sometimes make groundbreaking discoveries that
advance the boundaries of knowledge and human progress. Elsevier provides web-based,
digital solutions – among them ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Elsevier Research Intelligence
[http://www.elsevier.com/online-tools/research-intelligence ] and ClinicalKey
[https://www.clinicalkey.com ] – and publishes nearly 2,200 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and over 25,000 book titles,
including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading provider of professional information solutions in the Science, Medical,
Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange),
RUK and ENL (New York Stock Exchange).
Media contact Joanna Cipolla Elsevier +44-1865-843-477 email@example.com